CompaniesCellAct Pharma

CellAct Pharma

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

45

By Phase

PHASE2: 1

By Status

TERMINATED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
Today
NCT02094560
Hover over trial bars to see details

Recent Trials

NCT02094560Lead Sponsor
CAP7.1 for the Treatment of Advanced Stage, Therapy Refractory Lung and Biliary Tract Tumors
PHASE2Terminated
45 participants
Started: Nov 8, 2011 · Completed: Apr 10, 2017
Related Companies
Mundipharma
acquired